Con: Access to advanced therapies for severe asthma should be restricted to patients with satisfactory adherence to maintenance treatment
Sign Up to like & getrecommendations! Published in 2021 at "Breathe"
DOI: 10.1183/20734735.0049-2021
Abstract: Current guidance states that advanced therapies should only be used when adherence to maintenance therapy (inhaled corticosteroid/long-acting β-agonist) has been proven. This is based on the costs of advanced therapies, the fact that they were… read more here.
Keywords: adherence maintenance; poor adherence; maintenance; access ... See more keywords